Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Rizzolo

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 30, 2021
Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing EnzymesDaniel Rizzolo, Bo Kong, Stephanie Piekos, et al.
Egastroenterology|October 2, 2025
Ursodeoxycholic acid acts as an ileal FXR agonist in male mice with hepatic deficiency of FXRZakiyah R Henry, Syeda Maliha, Veronia Basaly, et al.
Hepatology Communications|May 16, 2025
Deletion of hepatic FXR leads to more severe MASH development in female miceZakiyah R Henry, Laura Armstrong, Syeda Maliha, et al.
Hepatology Communications|May 23, 2024
Effects of intestine-specific deletion of FGF15 on the development of fatty liver disease with vertical sleeve gastrectomyMonica D Chow, Katherine Otersen, Andrew Wassef, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 30, 2021
Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing EnzymesDaniel Rizzolo, Bo Kong, Stephanie Piekos, et al.
Egastroenterology|October 2, 2025
Ursodeoxycholic acid acts as an ileal FXR agonist in male mice with hepatic deficiency of FXRZakiyah R Henry, Syeda Maliha, Veronia Basaly, et al.
Hepatology Communications|May 16, 2025
Deletion of hepatic FXR leads to more severe MASH development in female miceZakiyah R Henry, Laura Armstrong, Syeda Maliha, et al.
Hepatology Communications|May 23, 2024
Effects of intestine-specific deletion of FGF15 on the development of fatty liver disease with vertical sleeve gastrectomyMonica D Chow, Katherine Otersen, Andrew Wassef, et al.
Pageof 2